M. Cushman
Surgery · 2001–2021
A researcher in the Science corpus: 30 papers; trusts 2 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Surgery — 330 citations into it
- Internal Medicine — 119 citations into it; #13 of 19 by trust here, #5 by citations
- Health, Toxicology and Mutagenesis — 20 citations into it
Whom M. Cushman trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts M. Cushman overall
Papers from M. Cushman's perspective
Ordered by how strongly the researchers M. Cushman trusts endorse each paper. Same corpus, a different order for every researcher.
- GRADE guidelines: 2. Framing the question and deciding on important outcomes. (Journal of Clinical Epidemiology)
- GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. (Journal of Clinical Epidemiology)
- Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. (American Journal of Medicine)
- C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. (New England Journal of Medicine)
- Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. (Archives of Internal Medicine)
- Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American… (Circulation)
- Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. (Circulation)
- Central challenges facing the national clinical research enterprise. (Journal of the American Medical Association (JAMA))
- Association between C-reactive protein and features of the metabolic syndrome: a population-based study. (Diabetes Care)
- Rosuvastatin in older patients with systolic heart failure. (Current Atherosclerosis Reports)
Their papers
- HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials (2015) — 671 citations
- Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19 (2021) — 704 citations
- Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 (2021) — 686 citations
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up (2020) — 2,222 citations
- Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association (2019) — 750 citations
- World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions (2019) — 908 citations
- Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association (2018) — 5,753 citations
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. (2018) — 665 citations
- Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association (2017) — 7,856 citations
- Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association (2016) — 6,770 citations
- Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (2012) — 2,418 citations
- C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction (2012) — 1,067 citations
- Community Prevalence of Ideal Cardiovascular Health, by the AHA Definition, and Relation to Cardiovascular Disease Incidence (2011) — 680 citations
- Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association (2011) — 1,734 citations
- Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension: A Scientific Statement From the American Heart Association (2011) — 2,052 citations
- Executive Summary: Heart Disease and Stroke Statistics—2015 Update A Report From the American Heart Association (2011) — 2,046 citations
- Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies (2010) — 620 citations
- Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association (2009) — 6,674 citations
- Ankle Brachial Index Combined with Framingham Risk Score to Predict Cardiovascular Events and Mortality: A Meta-analysis (2008) — 1,853 citations
- Epidemiology and risk factors for venous thrombosis. (2007) — 758 citations